Clinical Trials
7 trialsNCT03649061 2025-06-19
CareRA2020
Universitaire Ziekenhuizen KU Leuven
Phase 4 Completed
NCT00837434 2021-09-22
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 4 Completed
NCT02092467 2021-08-17
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Phase 4 Completed
NCT02364479 2019-12-19
Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
Sun Yat-sen University
Phase 4 Completed
NCT01053819 2018-02-23
Can We Miss Pigmented Lesions in Psoriasis Patients?
University of Alabama at Birmingham
Phase 4 Completed
NCT01295151 2016-11-02
SWITCH
University of Leeds
Phase 4 Completed
NCT00432406 2009-03-11
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Chinese University of Hong Kong
Phase 4 Completed